Thursday, Jul 18, 2019
engineered enzymes for better healthcare

Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits for newborn infants that will be of interest to emerging international markets...

Read full article on the web CSCB News, February 7, 2008 or in pdf format   pdf_button

Back to the News page

Language Selection

Search